| | FREE WEBINAR: Decoding the Vaginal Microbiome Don't miss the chance to hear Priyanka Jain, CEO & Co-Founder at Evvy discuss their mission to close the gender health gap by leveraging overlooked biomarkers and using metagenomic sequencing to better understand the vaginal microbiome. Register Now! |
|---|
A broken PACT? Biotech’s lone clinical asset put on ice as more staffers culled Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab Aeglea culls workers, shifts pipeline focus after knockback by FDA Bluebird exec spreads wings, heads over to Tessera for ‘irresistible opportunity’ FDA clears Point Robotics' hand-held spinal surgery system Johnson & Johnson lost to Pfizer in bidding war for Global Blood Therapeutics: Bloomberg Moderna, hoping to serve an ace with its new booster, taps Billie Jean King for its US Open campaign BCBS of Vermont sues Teva Pharmaceuticals over marketing for its MS drug Copaxone Thermo Fisher opens yet another production site, this one in Massachusetts for viral vectors AbbVie blood cancer survey reveals emotional roller coaster hitting patients Folx Health rises to the occasion with affirmative monkeypox care, education Pharma's new marketing mix brings closer collaboration with sales reps Featured Story | By Max Bayer PACT Pharma continues to spiral, disclosing that it would be laying off 51 additional staffers and suspending its phase 1 trial. The news comes just more than a month after the company laid off nearly 100 employees. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Third Harmonic Bio is braving the frosty IPO waters. With the weakest quarter for biotech IPOs in years still fresh in the memory, and the proceeds of a $105 million series B still in its bank account, the allergy and inflammatory disease startup has filed to tap public investors for cash to run early-phase trials. read more By Nick Paul Taylor Aeglea BioTherapeutics’ staffers are feeling the consequences of its failed attempt to bring a rare disease drug to market. Fresh from a rare refusal-to-file letter from the FDA, the biotech has shifted its focus to an earlier-phase prospect and reduced its head count. read more By Gabrielle Masson Anne-Virginie Eggimann joins Tessera, a gene writing and rewriting biotech, as chief regulatory officer after 11 years with Bluebird. read more By Andrea Park In contrast to other up-and-coming robotic surgery systems, one newly cleared by the FDA acts less like an autonomous assistant and more like a surgeon’s extra pair of hands. read more By Angus Liu Before settling on a $5.4 billion price tag for Global Blood Therapeutics, Pfizer had to fight off a mysterious “company A.” Now, the identity of that contender has been revealed. read more By Ben Adams As Moderna is gearing up to run a new COVID booster campaign this year in the U.S., it has scored tennis legend Billie Jean King as part of its U.S. Open sponsorship. read more By Frank Diamond Blue Cross and Blue Shield of Vermont and the Vermont Health Plan filed suit this week against Teva Pharmaceuticals, accusing the company of using some shady tactics to rake in money from its multiple sclerosis drug Copaxone. read more By Kevin Dunleavy For the second time this week, Thermo Fisher has opened a new manufacturing facility—this one dedicated to viral vector production in Plainville, Massachusetts. The 300,000-square-foot plant, located 40 miles south of the company’s headquarters in Waltham, will employ 300 people and manufacture viral vectors. read more By Jacqueline Renfrow Patients and caregivers undergo a unique emotional journey during the phases of chronic lymphocytic leukemia, but there is a major gap in support. read more By Annie Burky The Folx virtual primary care platform works to fill the gap of a slow national response to monkeypox by linking patients with clinicians in their state who have been thoroughly vetted by the app and trained on the virus. LGBTQ+ community members can now book an appointment to discuss the threat with a licensed clinician in 44 states. read more By Jacqueline Renfrow While pharma experienced a massive shift to digital sales brought on by the COVID-19 pandemic moving forward, a marketing mix that includes in-person touch points remains integral to building strong relationships in the pharmaceutical marketing industry. read more Resources Sponsored by: Ferma.AI, a Product of ZoomRx Improve your congress competitive intelligence and cut down costs by 50% Sponsored by: Catalent Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Bio-Techne Advanced research requires advanced tools. Our next-generation ELISA takes a fraction of the time to run eight analytes simultaneously while saving your sample volume. Simply load, scan, and insert your cartridge and come back to fully analyzed results in 75 minutes. Rethink your ELISA, with Ella. Sponsored by: Thermo Fisher Scientific Set a solid foundation for successful scale-up of buffer preparation. The total immersion, transformative training will take place at the Harvard Club in Boston. VIRTUAL in real time is also available. Contingencies for COVID19 will apply. Register NOW for a large early bird discount www.drugstomarket.com/drugbootcamp. Sponsored by: Triangle Insights Group, LLC The TrialCard/Triangle Insights Group platform is uniquely positioned to support you as your asset progresses through the value chain, by integrating strategic commercialization and market access insights with comprehensive patient and provider support services. Sponsored by: Thermo Fisher Scientific See how integration of innovative genetic analysis techniques into drug development is driving biopharma & biotech companies ahead. Sponsored by: Catalent What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent Carla Vozone discusses the significant trends in the OINDP segment including large molecules and novel indications, changes within CDMOs and various challenges facing the industry. Sponsored by: Catalent Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Events Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Free Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Drug Development Boot Camp® 2022 November 16-17, 2022 |
